financetom
Business
financetom
/
Business
/
Evolv Technologies Receives Nasdaq Noncompliance Notice
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evolv Technologies Receives Nasdaq Noncompliance Notice
Nov 22, 2024 2:10 PM

04:36 PM EST, 11/22/2024 (MT Newswires) -- Evolv Technologies ( EVLV ) said late Friday it has been notified by Nasdaq that it is not in compliance with the listing rule due to the delayed filing of its Form 10-Q report for the quarter ended Sept. 30.

The company attributed the delay to an internal investigation, which it said has substantially been completed, into certain sales practices that impacted revenue recognition and other metrics.

Evolv ( EVLV ) said it has been given until Jan. 20 to submit a plan to Nasdaq to comply with the listing rule. If accepted, the stock exchange could grant the company until May 19 to regain compliance.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Carriage Services Announces The Acquisition Of Faith Chapel Funeral Homes & Crematory In Pensacola
BRIEF-Carriage Services Announces The Acquisition Of Faith Chapel Funeral Homes & Crematory In Pensacola
Sep 17, 2025
Sept 17 (Reuters) - Carriage Services Inc ( CSV ): * CARRIAGE SERVICES ANNOUNCES THE ACQUISITION OF FAITH CHAPEL FUNERAL HOMES & CREMATORY IN PENSACOLA, FLORIDA Source text: Further company coverage: ...
Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party
Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party
Sep 17, 2025
Sept 17 (Reuters) - Drug developer Arvinas ( ARVN ) said on Wednesday it will grant commercialization rights of an experimental breast cancer treatment it was developing with Pfizer ( PFE ) to a third party. Shares of Arvinas ( ARVN ) were down 3.4% in extended trading. The drug vepdegestrant is currently under review by the U.S. Food and...
Arvinas Cuts More Jobs, Shifts Strategy on Breast Cancer Drug Development
Arvinas Cuts More Jobs, Shifts Strategy on Breast Cancer Drug Development
Sep 17, 2025
05:44 PM EDT, 09/17/2025 (MT Newswires) -- Arvinas ( ARVN ) plans to cut an additional 15% of its workforce, while the company and its partner Pfizer ( PFE ) look for another firm to take over the rights to sell and further develop vepdegestrant, a potential treatment for advanced breast cancer. The measures, combined with $80 million in annual...
Crypto Platform Bullish's Second Quarter Earnings Beats Wall Street's Estimates
Crypto Platform Bullish's Second Quarter Earnings Beats Wall Street's Estimates
Sep 17, 2025
Bullish (BLSH), the owner of CoinDesk, earnings per share beat average analyst estimates, while expecting higher adjusted Ebitda for the next quarter. The crypto platform reported earnings per share (EPS) of $0.93 in the second quarter, beating the average analyst estimate of $0.03, according to FactSet data. Bullish also reported adjusted revenue of $57 million for the second quarter, versus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved